X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (21023) 21023
Publication (1511) 1511
Newsletter (173) 173
Book Chapter (143) 143
Book Review (139) 139
Dissertation (41) 41
Conference Proceeding (32) 32
Magazine Article (31) 31
Book / eBook (8) 8
Reference (5) 5
Government Document (4) 4
Trade Publication Article (3) 3
Journal / eJournal (2) 2
Data Set (1) 1
Newspaper Article (1) 1
Paper (1) 1
Presentation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12929) 12929
female (7129) 7129
male (6895) 6895
animals (6847) 6847
index medicus (5468) 5468
oncology (5453) 5453
middle aged (4086) 4086
antineoplastic agents, alkylating - therapeutic use (4040) 4040
adult (3680) 3680
mice (3232) 3232
aged (3109) 3109
alkylating agents (3089) 3089
chemotherapy (2912) 2912
antineoplastic agents, alkylating - administration & dosage (2828) 2828
cancer (2590) 2590
alkylating agents - pharmacology (2394) 2394
antineoplastic agents, alkylating - pharmacology (2381) 2381
dacarbazine - analogs & derivatives (2369) 2369
alkylating-agents (2140) 2140
treatment outcome (2114) 2114
rats (2019) 2019
antineoplastic agents, alkylating - adverse effects (1950) 1950
pharmacology & pharmacy (1719) 1719
temozolomide (1682) 1682
combined modality therapy (1522) 1522
dacarbazine - therapeutic use (1483) 1483
dose-response relationship, drug (1462) 1462
biochemistry & molecular biology (1417) 1417
cyclophosphamide (1369) 1369
brain neoplasms - drug therapy (1351) 1351
antineoplastic combined chemotherapy protocols - therapeutic use (1350) 1350
cell line, tumor (1311) 1311
time factors (1299) 1299
toxicology (1296) 1296
dna repair (1251) 1251
alkylating agents - therapeutic use (1229) 1229
adolescent (1199) 1199
hematology (1192) 1192
dna damage (1177) 1177
dna (1135) 1135
retrospective studies (1129) 1129
research (1125) 1125
alkylating agents - toxicity (1122) 1122
apoptosis (1067) 1067
radiotherapy (1053) 1053
therapy (1052) 1052
care and treatment (1006) 1006
cyclophosphamide - administration & dosage (990) 990
analysis (974) 974
child (971) 971
prognosis (956) 956
aged, 80 and over (945) 945
antineoplastic agents (944) 944
alkylation (940) 940
glioblastoma (923) 923
expression (908) 908
tumor cells, cultured (891) 891
follow-up studies (887) 887
surgery (874) 874
antineoplastic agents - therapeutic use (873) 873
alkylating agents - administration & dosage (863) 863
cyclophosphamide - therapeutic use (863) 863
cell survival - drug effects (858) 858
genetics & heredity (858) 858
medicine & public health (858) 858
mutation (857) 857
clinical neurology (842) 842
tumors (842) 842
glioblastoma - drug therapy (834) 834
antineoplastic agents - pharmacology (818) 818
disease-free survival (774) 774
apoptosis - drug effects (771) 771
neoplasms - drug therapy (765) 765
survival (764) 764
cells (731) 731
toxicity (708) 708
survival analysis (706) 706
dacarbazine - pharmacology (699) 699
survival rate (693) 693
article (673) 673
brain neoplasms - pathology (673) 673
chemistry, medicinal (666) 666
kinetics (646) 646
melphalan - administration & dosage (646) 646
child, preschool (641) 641
glioma - drug therapy (639) 639
cell line (628) 628
antimitotic agents (626) 626
drug resistance (621) 621
dna - metabolism (619) 619
antineoplastic agents, alkylating - toxicity (618) 618
young adult (613) 613
drug administration schedule (610) 610
transplantation (597) 597
cell biology (592) 592
ophthalmology (590) 590
melphalan (588) 588
health aspects (578) 578
structure-activity relationship (578) 578
antineoplastic agents, alkylating - pharmacokinetics (576) 576
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (19806) 19806
Russian (396) 396
German (324) 324
French (305) 305
Japanese (194) 194
Chinese (103) 103
Italian (52) 52
Polish (52) 52
Spanish (51) 51
Hungarian (20) 20
Czech (19) 19
Norwegian (11) 11
Portuguese (11) 11
Ukrainian (11) 11
Dutch (7) 7
Korean (7) 7
Bulgarian (6) 6
Finnish (6) 6
Swedish (6) 6
Hebrew (5) 5
Serbian (5) 5
Croatian (4) 4
Danish (4) 4
Lithuanian (4) 4
Slovak (2) 2
Romanian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 8/2011, Volume 68, Issue 2, pp. 445 - 455
The natural flavonoid fisetin was recently identified as a lead compound that stabilizes endothelial cell microtubules. In this study, we investigated the... 
Fisetin | Lewis lung carcinoma | Angiogenesis | Antitumour activity | Cyclophosphamide | Medicine & Public Health | Cancer Research | Oncology | Cytotoxicity | EA·hy 926 endothelial cells | Pharmacology/Toxicology | Flavonoid | EA•hy 926 endothelial cells | APOPTOSIS | ANTIINFLAMMATORY ACTIVITY | ACTIVATION | CELL-CYCLE ARREST | PROLIFERATION | METASTATIC COLORECTAL-CANCER | IN-VITRO | ONCOLOGY | ENDOTHELIAL-CELLS | PHARMACOLOGY & PHARMACY | EA.hy 926 endothelial cells | INHIBITORS | NIH 3T3 Cells | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Tubulin Modulators - pharmacology | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents, Alkylating - pharmacology | Flavonoids - adverse effects | Antineoplastic Agents, Alkylating - administration & dosage | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Flavonoids - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Angiogenesis Inhibitors - administration & dosage | Antineoplastic Agents, Phytogenic - administration & dosage | Angiogenesis Inhibitors - therapeutic use | Flavonoids - administration & dosage | Tubulin Modulators - administration & dosage | Female | Flavonoids - pharmacology | Antineoplastic Agents, Phytogenic - therapeutic use | Angiogenesis Inhibitors - adverse effects | Antineoplastic Agents, Phytogenic - adverse effects | Cell Line | Cell Survival - drug effects | Tubulin Modulators - adverse effects | Mice, Inbred C57BL | Angiogenesis Inhibitors - pharmacology | Tubulin Modulators - therapeutic use | Carcinoma, Lewis Lung - drug therapy | Antineoplastic Agents, Alkylating - therapeutic use | Cell Movement - drug effects | Animals | Tumor Burden - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Endothelial Cells - cytology | Neovascularization, Pathologic - drug therapy | Cyclophosphamide - pharmacology | Carcinoma, Lewis Lung - pathology | Cell Proliferation - drug effects | Mice | Antineoplastic Agents, Alkylating - adverse effects | Antineoplastic Agents, Phytogenic - pharmacology | Cell Cycle - drug effects | Endothelial Cells - drug effects | Antimitotic agents | Flavonoids | Flavones | Lung cancer | Bioflavonoids | Accountants | Drug therapy, Combination | Universities and colleges | Antineoplastic agents | Endothelium | Tumors | Index Medicus | cytology | Antineoplastic Agents, Phytogenic | pathology | Cell Proliferation | Endothelial Cells | Tubulin Modulators | Neovascularization, Pathologic | fisetin | administration & dosage | pharmacology | flavonoid | Carcinoma, Lewis Lung | Antineoplastic Agents, Alkylating | cytotoxicity | drug therapy | Cell Survival | angiogenesis | Antineoplastic Combined Chemotherapy Protocols | drug effects | Tumor Burden | Angiogenesis Inhibitors | EA.hy 926 | Cell Cycle | antitumour activity | adverse effects | therapeutic use | Cell Movement
Journal Article
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 01/2014, Volume 61, Issue 1, pp. 53 - 67
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 12/2016, Volume 15, Issue 12, pp. 3000 - 3014
Journal Article
Materials Science & Engineering C, ISSN 0928-4931, 04/2016, Volume 61, pp. 1002 - 1017
Small molecules that bind genomic DNA have proven that they can be effective anticancer, antibiotic and antiviral therapeutic agents that affect the well-being... 
Drug discovery | DNA hybridization | Drug–DNA interaction | DNA damage | Electrochemical DNA biosensor | Pharmacogenomics | Drug-DNA interaction | MATERIALS SCIENCE, BIOMATERIALS | ANTICANCER DRUG | SITU ELECTROCHEMICAL EVALUATION | DOUBLE-STRANDED DNA | CARBON NANOTUBES | WASTE-WATER SAMPLES | BREAST-CANCER | PENCIL GRAPHITE ELECTRODE | SURFACE-CONFINED DNA | CYCLIC VOLTAMMETRY | ACTIVATED MITOMYCIN-C | Anti-Bacterial Agents - analysis | Pharmacogenetics | Electrochemical Techniques | Alkylating Agents - pharmacology | Humans | Anti-Bacterial Agents - metabolism | Antineoplastic Agents - analysis | Intercalating Agents - pharmacology | DNA - metabolism | DNA Cleavage - drug effects | Alkylating Agents - metabolism | DNA - chemistry | Intercalating Agents - metabolism | Pharmaceutical Preparations - metabolism | DNA - analysis | Biosensing Techniques | Pharmaceutical Preparations - chemistry | Alkylating Agents - analysis | Nanostructures - chemistry | Anti-Bacterial Agents - pharmacology | Antineoplastic Agents - pharmacology | Intercalating Agents - analysis | Pharmaceutical Preparations - analysis | Antiviral agents | Usage | DNA replication | Drug interactions | DNA | Genetic research | Electrochemistry | Electric properties | Drugs | Deoxyribonucleic acid | Strands | Materials science | Nanostructure | Cognition | Biosensors | Binding sites
Journal Article